Click to Share

Filter News
Show All Results
News By Country
News By Tag
Liver Disease Remove

July 2020

Public Company News

Business Press Releases

Liver Disease Press Releases

Exclusive News
Topics Locations Industries Dates

By SFA Therapeutics, Inc.
SFA Therapeutics, Inc. announced today that FDA has granted an official Orphan Drug Designation (ODD) to SFA001, the company's novel human-microbiome-based treatment for human hepatocellular carcinoma (HCC).

Page updated every 10 minutes

Like PRLog?
Click to Share